Acosta Jessica P, Lee Su A, Fickler Anna, Stein Hans H
Division of Nutritional Sciences, University of Illinois, Urbana, IL, 61801, USA.
Department of Animal Sciences, University of Illinois, Urbana, IL, 61801, USA.
Transl Anim Sci. 2025 May 4;9:txaf061. doi: 10.1093/tas/txaf061. eCollection 2025.
The hypothesis that a novel endo-β-mannanase can be used in diets for weanling pigs without negatively impacting growth performance, serum chemistry, hematological characters, or organ weights was tested. A total of 150 newly weaned pigs (75 castrated male and 75 female pigs; initial body weight: 6.20 ± 0.68 kg) were used. Pigs were allotted to three experimental diets (i.e., control, control plus 800 thermostable mannanase units ()/kg, or control plus 100,000 TMU/kg). Pigs were allotted to pens with 5 pigs per pen for a total of 10 replicate pens per treatment. Pigs were fed phase 1 diets from d 1 to 21, and phase 2 diets from d 22 to 42 post-weaning. Average daily gain (), average daily feed intake (), and gain:feed () were calculated. Blood samples from two pigs per pen (one male and one female pig) were collected on d 1, 21, and 42. One pig per pen from the control treatment and two pigs per pen from each of the β-mannanase treatments were euthanized at the end of the experiment and organs were collected. Data were analyzed using the Proc MIXED procedure of SAS with pen as the experimental unit. Results indicated that for the overall experiment, there were no differences in ADG, ADFI, or final body weight among treatments. However, pigs fed the diet with 100,000 TMU/kg of β-mannanase had greater (< 0.05) G:F from d 22 to 42 and for the overall experimental period compared with pigs fed the control diet or the diet with 800 TMU/kg of β-mannanase. Most serum chemistry markers and blood hematological characters were not different among pigs fed experimental diets and concentrations were within the normal biological range for pigs. However, serum phosphorus was greater (< 0.05) in pigs fed the diet with 100,000 TMU/kg of β-mannanase compared with pigs fed the other diets, but red cell distribution width and mean platelet volume were greater (< 0.05) in pigs fed the control diet compared with pigs fed the control diet + 800 TMU/kg of β-mannanase. Abnormalities in liver, kidney, spleen, heart, stomach, or the small intestine were not observed, and the weight of these organs was not affected by dietary treatments. In conclusion, pigs fed diets containing 100,000 TMU/kg of β-mannanase had greater G:F from d 1 to 42 post-weaning compared with pigs fed control diets or the diets with 800 TMU/kg, and β-mannanase did not negatively impact general health and growth of the pigs even if included at a very high dose.
本研究对一种新型内切β-甘露聚糖酶能否用于断奶仔猪日粮且不负面影响其生长性能、血清生化指标、血液学特征或器官重量的假设进行了验证。共选用150头刚断奶仔猪(75头去势公猪和75头母猪;初始体重:6.20±0.68千克)。将仔猪分配到三种试验日粮组(即对照组、对照组+800热稳定甘露聚糖酶单位(TMU)/千克或对照组+100,000 TMU/千克)。每栏饲养5头猪,每种处理共设10个重复栏。仔猪在断奶后第1天至21天饲喂1期日粮,第22天至42天饲喂2期日粮。计算平均日增重(ADG)、平均日采食量(ADFI)和料重比(G:F)。在第1天、21天和42天,从每栏中选取2头猪(1头公猪和1头母猪)采集血样。在试验结束时,对对照组每栏选取1头猪,β-甘露聚糖酶处理组每栏选取2头猪实施安乐死并采集器官。数据采用SAS的Proc MIXED程序进行分析,以栏为试验单位。结果表明,在整个试验中,各处理组的ADG、ADFI或末重均无差异。然而,与饲喂对照日粮或含800 TMU/千克β-甘露聚糖酶日粮的仔猪相比,饲喂含100,000 TMU/千克β-甘露聚糖酶日粮的仔猪在断奶后第22天至42天以及整个试验期的G:F更高(P<0.05)。大多数血清生化指标和血液学特征在饲喂试验日粮的仔猪之间无差异,且浓度处于猪的正常生物学范围内。然而,与饲喂其他日粮的仔猪相比,饲喂含100,000 TMU/千克β-甘露聚糖酶日粮的仔猪血清磷更高(P<0.05),但与饲喂对照日粮+800 TMU/千克β-甘露聚糖酶日粮的仔猪相比,饲喂对照日粮的仔猪红细胞分布宽度和平均血小板体积更大(P<0.05)。未观察到肝脏、肾脏、脾脏、心脏、胃或小肠的异常,且这些器官的重量不受日粮处理的影响。总之,与饲喂对照日粮或含800 TMU/千克β-甘露聚糖酶日粮的仔猪相比,饲喂含100,000 TMU/千克β-甘露聚糖酶日粮的仔猪在断奶后第1天至42天的G:F更高,且即使β-甘露聚糖酶以非常高的剂量添加,也不会对猪的总体健康和生长产生负面影响。